Seminar for physicians: modern IHC capabilities in oncology
Admin
On February 15, 2026, EPL Lab conducted an educational seminar "Modern IHC capabilities in oncology: from diagnosis to therapy selection" for oncologists, surgeons, and therapists.
The seminar covered topics: using PD-L1 as a predictive marker for immunotherapy, IHC diagnostic algorithms for cancers of unknown primary (CUP syndrome), the role of Ki-67 and hormone receptors in breast cancer.
Over 80 physicians from Kyiv and the regions participated. We plan to make these events regular — once a quarter — to keep our colleagues updated on the latest diagnostic achievements.